- Home
- IPGP vs PTGX Comparison
IPGP vs PTGX Comparison
Compare IPGP & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPGP
- PTGX
- Stock Information
- Founded
- IPGP 1990
- PTGX 2006
- Country
- IPGP United States
- PTGX United States
- Employees
- IPGP N/A
- PTGX N/A
- Industry
- IPGP Semiconductors
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- IPGP Technology
- PTGX Health Care
- Exchange
- IPGP Nasdaq
- PTGX Nasdaq
- Market Cap
- IPGP 3.0B
- PTGX 3.3B
- IPO Year
- IPGP 2006
- PTGX 2016
- Fundamental
- Price
- IPGP $74.15
- PTGX $53.00
- Analyst Decision
- IPGP Buy
- PTGX Strong Buy
- Analyst Count
- IPGP 7
- PTGX 9
- Target Price
- IPGP $72.75
- PTGX $67.11
- AVG Volume (30 Days)
- IPGP 226.3K
- PTGX 923.4K
- Earning Date
- IPGP 07-29-2025
- PTGX 08-05-2025
- Dividend Yield
- IPGP N/A
- PTGX N/A
- EPS Growth
- IPGP N/A
- PTGX N/A
- EPS
- IPGP N/A
- PTGX 0.86
- Revenue
- IPGP $952,918,000.00
- PTGX $207,801,000.00
- Revenue This Year
- IPGP N/A
- PTGX N/A
- Revenue Next Year
- IPGP $7.66
- PTGX $53.09
- P/E Ratio
- IPGP N/A
- PTGX $61.48
- Revenue Growth
- IPGP N/A
- PTGX N/A
- 52 Week Low
- IPGP $48.59
- PTGX $32.50
- 52 Week High
- IPGP $92.21
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- IPGP 64.72
- PTGX 53.99
- Support Level
- IPGP $71.02
- PTGX $49.38
- Resistance Level
- IPGP $75.47
- PTGX $51.51
- Average True Range (ATR)
- IPGP 2.21
- PTGX 2.02
- MACD
- IPGP 0.40
- PTGX -0.39
- Stochastic Oscillator
- IPGP 86.57
- PTGX 46.09
About IPGP IPG Photonics Corporation
IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, fiber amplifiers, and diode lasers, which are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. The company operates in one segment which involves the design, development, production and distribution of fiber lasers, laser and non-laser systems, fiber amplifiers, and related optical components. A large majority of the firm's revenue is derived from materials processing applications for fiber lasers, including cutting and welding, marking and engraving, and micro-processing. The company generates a majority of its revenue from North America and also has its presence in China, Japan, Germany, and other markets.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.